Morning trading October 22, page-736

  1. 3,367 Posts.
    lightbulb Created with Sketch. 623
    I compared a few at the time but settled on PAB.

    There is a lot to like. The chart was an easy buy.

    Clinical trials next year and low market cap so plenty of run way for increase in SP.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.